Bavencio Interactions
There are 597 drugs known to interact with Bavencio (avelumab), along with 10 disease interactions. Of the total drug interactions, 3 are major, and 594 are moderate.
- View all 597 medications that may interact with Bavencio
- View Bavencio disease interactions (10)
Most frequently checked interactions
View interaction reports for Bavencio (avelumab) and the medicines listed below.
- Abilify MyCite (aripiprazole)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- Aggrenox (aspirin / dipyridamole)
- Akynzeo (netupitant / palonosetron)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- alprazolam
- Alprazolam Intensol (alprazolam)
- Amicar (aminocaproic acid)
- amoxicillin
- Apresazide (hydralazine / hydrochlorothiazide)
- Aptivus (tipranavir)
- Arava (leflunomide)
- Aricept (donepezil)
- Arzerra (ofatumumab)
- Asendin (amoxapine)
- Combivent Respimat (albuterol / ipratropium)
- DuoNeb (albuterol / ipratropium)
- Lyrica (pregabalin)
- Sabril (vigabatrin)
- Symbicort (budesonide / formoterol)
- Tecentriq (atezolizumab)
Bavencio disease interactions
There are 10 disease interactions with Bavencio (avelumab) which include:
- hepatic impairment
- adrenal insufficiency
- colitis
- diabetes
- pneumonitis
- renal dysfunction
- thyroid disease
- HSCT
- myasthenia gravis
- organ transplant
Report options
QR code containing a link to this page
More about Bavencio (avelumab)
- Bavencio consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
